A literature search of the LncRNADisease database (37) found that most of these pathways were previously associated with H19 (Figure 3C), confirming that H19 is an important regulator in many types of cancers and can therefore be used as a potential tumor marker for initial diagnosis and monitoring of therapies. This evidence concerns the gene H19 and neoplasm.